Latest News

  • How to build an insight-led campaign when you don’t have the data yet

    By EatMoreFruit Communications Most healthcare campaigns targeting clinicians start with the product and work backwards. The most effective ones start by mapping where knowledge gaps, clinical objections, and real-world barriers exist. Here's how we approached building an insight-led strategy for a wound dressing when the data didn't exist in tidy reports. Marketing directors in medical [...]

  • GravityLabs raises US$17m series A funding

    GravityLabs has closed a US$17m series A to speed its US expansion, open a local office, relocate staff and hire, while advancing its AI health app. Founded in 2022 by chief executive Woonyeon Kim, GravityLabs is best known for Moneywalk, a gamified health app that uses rewards, challenges and community features to encourage daily activity. [...]

  • IIHMR to open AMTZ satellite centre in Visakhapatnam

    IIHMR Delhi and AMTZ have signed an MoU to open a satellite centre at Andhra Pradesh MedTech Zone in Visakhapatnam, offering training and applied research. An MoU is a formal collaboration agreement between organisations. Under the partnership, IIHMR Delhi will set up a satellite centre on the AMTZ campus to deliver executive education programmes, industry-aligned [...]

  • 2026 health tech predictions: From AI scribes to digital pathology

    By Klaus Boehncke, global digital health lead, Guillaume Duparc, healthcare partner, and Levin Laske, healthcare principal, L.E.K. Consulting In 2025, the world of healthcare and medical technology has been defined by increased AI adoption and integration into clinical systems, with recent findings outlining that AI-focused deals now make up 75 per cent of health tech funding. From [...]

  • Business roundup: World’s first AI orchestrator data platform for healthcare launches and more

    Health Tech World explores the latest business developments in the world of health technology. The world's first AI orchestrator data platform for healthcare launches McCrae Tech has launched the world's first health AI orchestrator called Orchestral. Orchestral is a health-native AI orchestrator data platform that connects diverse data sources with AI agents, workflows, and algorithms, [...]

  • Oneview and Peterson partnership on patient experience

    Oneview Healthcare has agreed a partnership with Peterson Health to deploy its Care Experience Platform across all inpatient rooms in Kerrville, Texas. Announced on 18 December 2025, the rollout includes 22-inch bedside touchscreens on swing arms and 43-inch digital whiteboards integrated with Meditech Expanse EHR (electronic health record). The tools provide real-time clinical information, support [...]

  • inbs, Vlepis team up on wearable monitoring

    Intelligent Bio Solutions has signed a non-exclusive strategic alliance with Vlepis to develop wearable screening tools and speed its move into consumer health monitoring. Announced on 18 December 2025, the alliance pools research and development, distribution and regulatory expertise to support a faster international rollout. Non-invasive means tests that do not puncture the skin. Wearable [...]

  • GlycanAge raises €7.4m for ageing diagnostics

    GlycanAge has raised €7.4m to expand glycan testing and bring ageing diagnostics into mainstream care. Glycans are complex sugars that coat cells and many proteins, helping control immunity and cell signalling. GlycanAge reads these signals, including an “inflammaging” clock based on IgG glycosylation (sugar chains added to antibodies), to estimate biological age and the impact [...]

  • BioNTech completes CureVac acquisition

    BioNTech has closed its acquisition of CureVac, ending the subsequent offering period and setting up a push to expand mRNA design, delivery and manufacturing. The subsequent offering period expired at 12:01am Eastern Time on 18 December 2025, the company said. BioNTech said 195,341,219 CureVac shares, about 86.75 per cent of those issued and outstanding, were [...]

  • VYNE and Yarrow agree merger to advance YB-101

    VYNE and Yarrow agreed a merger to form Yarrow Bioscience and advance YB-101, a TSH receptor antibody for Graves’ and thyroid eye disease. The all-stock deal will see the combined company operate as Yarrow Bioscience and list on Nasdaq under YARW, subject to approvals. Closing is targeted for the second quarter of 2026. Pre-closing financings [...]